Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00652067
Other study ID # 0604001371
Secondary ID
Status Completed
Phase N/A
First received March 31, 2008
Last updated April 2, 2008
Start date May 2006
Est. completion date May 2007

Study information

Verified date March 2008
Source Yale University
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

This protocol is an single patient IND to provide clofazamine to treat one patient who has MAI and is resistant to or can not tolerate standard of care. The drug is not otherwise available.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date May 2007
Est. primary completion date May 2007
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Treatment of one patient with MAI

Exclusion Criteria:

- No other patients will be treated

Study Design

N/A


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Yale University